Akèy › Limfòm Burkitt › New York › Rochester
Etid klinik pou Limfòm Burkitt nan Rochester, NY
4 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Ap rekriteFaz 3
- University of Rochester, Rochester
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Ap rekriteFaz 2
- University of Rochester, Rochester
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Ap rekriteFaz 2
- University of Rochester, Rochester
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Ap rekriteFaz 3
- University of Rochester, Rochester
Etid Limfòm Burkitt nan lòt vil
- Houston, TX21 etid
- Philadelphia, PA16 etid
- Milwaukee, WI16 etid
- Chicago, IL15 etid
- Cincinnati, OH13 etid
- New York City, NY13 etid
- Atlanta, GA12 etid
- Aurora, CO11 etid
- Seattle, WA11 etid
- Durham, NC10 etid
- Boston, MA10 etid
- Kansas City, MO10 etid
Lòt etid nan Rochester
- Leksemi mieloïd egi16 etid
- Kansè poumon15 etid
- Kansè nan tete15 etid
- Kansè (tout kalite)14 etid
- Obèsite14 etid
- Sipwa13 etid
- Kansè Poumon ki pa ti selil13 etid
- Kansè pwostat10 etid
- Kansè Metastatik8 etid
- Myelom Miltip8 etid
- Kansè vejik7 etid
- Distrofi myotonik7 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.